Increase in body weight is lowered when mice received fecal microbiota transfer from donor mice treated with the AT<sub>1</sub> receptor antagonist telmisartan.

Front Pharmacol · 2024 · PMC11608989 · PMID 39624839

Europe PMC DOI

hedged sentence

0.0660

closest p · 1.3× alpha

0.0660

boldest claim

The sentences

not quite reach the level of significancep = 0.066so close (0.05 < p ≤ 0.1)

At time d101, at the end of the trial, alpha diversity did not quite reach the level of significance ( p = 0.066) between the BL/6>f TEL and the BL/6>f VEH mice ( Figure 4A .

also in 16 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.